iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Shares Shorted: Short Interest Up 847.2% in September

by · The Markets Daily

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Get Free Report) saw a significant increase in short interest in the month of September. As of September 30th, there was short interest totaling 218,618 shares, an increase of 847.2% from the September 15th total of 23,081 shares. Based on an average trading volume of 209,979 shares, the short-interest ratio is currently 1.0 days. Currently, 2.9% of the shares of the company are short sold.

iShares Genomics Immunology and Healthcare ETF Stock Up 4.3%

Shares of iShares Genomics Immunology and Healthcare ETF stock traded up $1.75 on Friday, hitting $42.17. The stock had a trading volume of 151,574 shares, compared to its average volume of 67,732. iShares Genomics Immunology and Healthcare ETF has a twelve month low of $23.90 and a twelve month high of $43.44. The business’s 50 day moving average is $38.99 and its two-hundred day moving average is $33.61. The stock has a market cap of $318.38 million, a price-to-earnings ratio of 14.76 and a beta of 0.94.

Institutional Trading of iShares Genomics Immunology and Healthcare ETF

A hedge fund recently bought a new position in iShares Genomics Immunology and Healthcare ETF stock. NewEdge Advisors LLC acquired a new position in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 961 shares of the company’s stock, valued at approximately $32,000.

iShares Genomics Immunology and Healthcare ETF Company Profile

(Get Free Report)

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.

See Also